Berlin, Germany

Margrit Hillmann


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 43(Granted Patents)


Company Filing History:


Years Active: 2000-2006

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Margrit Hillmann: Innovator in Medicinal Chemistry

Introduction

Margrit Hillmann is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of medicinal chemistry, particularly through her innovative research and development of pharmaceutical compounds. With a total of 8 patents to her name, Hillmann has established herself as a key figure in her industry.

Latest Patents

Among her latest patents are two notable inventions. The first is related to benzoxazine and benzothiazine derivatives, which are utilized in medicaments. This invention encompasses compounds of formula (I), including their tautomeric and isomeric forms and salts, along with methods for their production and application in medicinal uses. The second patent focuses on aminoalkyl-3,4-dihydroquinoline derivatives, which serve as no-synthase inhibitors. This patent details the production process of these derivatives and their application in pharmaceutical agents.

Career Highlights

Margrit Hillmann has had a distinguished career, working with Schering Aktiengesellschaft, a leading pharmaceutical company. Her work has been instrumental in advancing the development of new therapeutic agents, showcasing her expertise in medicinal chemistry and innovation.

Collaborations

Throughout her career, Hillmann has collaborated with esteemed colleagues, including Hartmut Rehwinkel and Gerardine Anne Burton. These partnerships have further enriched her research and contributed to the success of her inventions.

Conclusion

Margrit Hillmann's contributions to medicinal chemistry through her patents and collaborations highlight her role as an influential inventor. Her work continues to impact the pharmaceutical industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…